More recently, a population of CD39+CD73+ B regulatory (Breg) cells has also been described in the TME of head and neck cancer patients, while peripheral blood B effector (Beff) cells were found to predominantly express A2AR rather than A3R (32). This evidence concerns the gene ENTPD1 and head and neck cancer.